Titan Pharmaceuticals has completed preclinical study of its long-term,non-fluctuating dopamine agonist,as a treatment for Parkinson's disease. The preclinical study included in-vitro characterization of implant formulations of two ...
Tags: Titan Pharmaceuticals, Parkinson's disease, ProNeura drug